SERPINA1 and liver cancer: Understanding the theoretical underpinnings behind VC-induced AAT resistance, and delving into the intricate landscape of the tumor immune microenvironment within VC may yield fresh insights and innovative approaches toward precision-based therapies for liver cancer.